In lab tests the four-amino-acid peptide blocked DPP-IV, an enzyme tied to blood sugar control. The authors say it's unclear whether the body makes enough of it to matter.
Recap by typeshit. Full story at UA.NEWS.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
Dr. Jen Caudle flags gaps in what social media says about retatrutide, the Lilly drug still in trials, and asks viewers to comment for more.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Loading…